Wednesday, August 5, 2026

Pete Hegseth Announces $25 Billion Spent on the War with Iran Since Feb 28

U.S. Defense Secretary Hegseth discusses $25B spent on Iran war, challenges Democrats, and emphasizes NATO and Indo-Pacific defense priorities.

North Korea Starts Building Barriers on Gyeongui Line After Explosive Severance

North Korea fortifies Gyeongui Line after severing ties with South Korea, raising concerns over potential military buildup.

2026 North Korea Missile Developments: How New Technologies Challenge U.S.-South Korea Intelligence

North Korea's missile upgrades challenge U.S. and South Korean intelligence, causing confusion in assessments and raising security concerns.

Health

“Improved Survival Rates”… Carboplatin Combination Therapy Shows Benefit in Triple-Negative Breast Cancer

Adding carboplatin to chemotherapy for operable triple-negative breast cancer reduces recurrence risk and improves survival, study finds.

Inventage Lab Selected for Global TIPS Program, Accelerating Late-Stage Development of Addiction Treatment

Inventis Lab's long-acting drug IVL3004 for addiction treatment has been selected for the Global TIPS research project by the Ministry of SMEs.

Bukwang Pharm Signs Export Agreement With Thailand’s Pacific Healthcare for Dexid

Bukwang Pharmaceutical signs exclusive export contract for diabetes treatment 'Dexide' with Pacific Healthcare in Thailand.

Huawei Unveils OpenPangu 2.0 Pro: Is This the Future of AI with 505 Billion Parameters?

Huawei accelerates its AI ecosystem expansion by revealing the source of its massive AI model with over 500 billion parameters.

AI-Driven Preclinical Platform: Revolutionizing Infectious Disease Treatment and Vaccine Development by 2030

An AI-based digital preclinical platform is being developed to expedite the creation of treatments and vaccines for emerging infectious diseases.
Latest

Can a Keto Diet Cure Schizophrenia? Robert F. Kennedy Jr.’s Controversial Claims Examined

U.S. Health Secretary Kennedy claims the ketogenic diet can treat schizophrenia, but experts warn of unsupported evidence and health risks.

Hanmi Posts Record $1.16B Sales and $193M Operating Profit: What’s Driving the 2025 Surge

Hanmi Pharmaceutical reports record sales of $1.16 billion in January 2025, with significant growth in profits and new product launches.

FDA Grants Breakthrough Therapy Designation to Hanmi’s Epheglucagon: What This Means for Rare Disease Treatment

Hanmi Pharmaceutical's efpegerglucagon receives FDA Breakthrough Therapy designation for treating rare Congenital Hyperinsulinism, with Phase 2 results due soon.

Elanco’s Vision for 2030: Key Insights from CEO Jeffrey Simmons’ Visit to South Korea

Elanco CEO Jeffrey Simmons visited South Korea to discuss growth strategies, celebrate anniversaries, and emphasize employee partnership.

K-Beauty Boom: How Classys, Hugel, and Wontech are Expanding in Global Markets

The K-beauty industry is growing, leveraging strong manufacturing and R&D capabilities alongside the global spread of Hallyu.

Celltrion Gets Global IB Upgrades: Morgan Stanley Raises Target to $206.25 as New Biosimilars Lift Margins

Celltrion is expanding through biosimilars and new drug development, attracting global investor interest and raising target stock prices.

CM Hospital’s thynC System: The Future of Patient Monitoring and Safety in Healthcare

Daewoong Pharmaceutical launches thynC, an AI-powered monitoring system at CM Hospital to enhance patient safety and healthcare quality.

Rokit Healthcare Secures UAE Patent for AI-Based Cartilage Regeneration: A Game-Changer in Middle Eastern Joint Treatment

Rokit Healthcare secures a UAE patent for AI cartilage regeneration, targeting a $682M market and shifting focus to regenerative medicine.

How ABL Bio’s Grabody-B Revolutionizes siRNA Delivery: A Game-Changer for Brain Disease Treatment?

ABL Bio's Grabody-B technology effectively delivers siRNA across the blood-brain barrier, enhancing treatment for brain and systemic diseases.

How LG CNS and FuriosaAI Are Revolutionizing AI Infrastructure for the Public Sector

LG CNS partners with FuriosaAI to enhance AI services using neural processing units, targeting the public AI transformation market.

SJN314: The Promising New Immunotherapy for Chronic Inflammatory Diseases in Asia

Samjin Pharmaceutical submits phase 1 trial plan for SJN314, targeting immune diseases, aiming for global partnerships in early clinical phases.

Revolutionary Vascular Wall Plug: How This New Device Enhances Blood Flow Control in 2026

Researchers unveil a novel vascular wall plug that enhances hemostasis and regulates blood flow, improving vascular procedure outcomes.

Samsung Biologics Joins CEPI: How This Partnership Will Revolutionize Vaccine Production in Asia

Samsung Biologics partners with CEPI to enhance vaccine manufacturing, aiming to strengthen global health security and support local biotech growth.

How thynC™ is Revolutionizing Patient Monitoring: Insights from Seers Technology’s Success

Seers Technology aims for global expansion, projecting overseas sales to match domestic by 2029, driven by its innovative AI healthcare solutions.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.